Operating Income (Loss) in USD of Xenetic Biosciences, Inc. from Q4 2011 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Xenetic Biosciences, Inc. quarterly/annual Operating Income (Loss) history and change rate from Q4 2011 to Q3 2025.
  • Xenetic Biosciences, Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$545K, a 9.06% decline year-over-year.
  • Xenetic Biosciences, Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$3.31M, a 24.1% increase year-over-year.
  • Xenetic Biosciences, Inc. annual Operating Income (Loss) for 2024 was -$4.2M, a 6.89% increase from 2023.
  • Xenetic Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$4.52M, a 32.8% increase from 2022.
  • Xenetic Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$6.72M, a 16.9% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Xenetic Biosciences, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$3.31M -$545K -$45.3K -9.06% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025
Q2 2025 -$3.27M -$724K +$613K +45.8% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025
Q1 2025 -$3.88M -$942K +$326K +25.7% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025
Q4 2024 -$4.2M -$1.1M +$157K +12.5% 01 Oct 2024 31 Dec 2024 10-K 18 Mar 2025
Q3 2024 -$4.36M -$499K +$647K +56.4% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025
Q2 2024 -$5.01M -$1.34M -$139K -11.6% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025
Q1 2024 -$4.87M -$1.27M -$353K -38.6% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025
Q4 2023 -$4.52M -$1.26M +$308K +19.7% 01 Oct 2023 31 Dec 2023 10-K 18 Mar 2025
Q3 2023 -$4.82M -$1.15M -$299K -35.3% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 -$4.52M -$1.2M +$1.49M +55.4% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024
Q1 2023 -$6.01M -$915K +$705K +43.5% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024
Q4 2022 -$6.72M -$1.56M +$311K +16.6% 01 Oct 2022 31 Dec 2022 10-K 21 Mar 2024
Q3 2022 -$7.03M -$848K +$528K +38.4% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 -$7.56M -$2.69M -$1.56M -138% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023
Q1 2022 -$6M -$1.62M -$251K -18.3% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 -$5.75M -$1.87M -$654K -53.6% 01 Oct 2021 31 Dec 2021 10-K 22 Mar 2023
Q3 2021 -$5.09M -$1.38M +$9.13M +86.9% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 -$14.2M -$1.13M -$145K -14.8% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022
Q1 2021 -$14.1M -$1.37M -$138K -11.2% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q4 2020 -$13.9M -$1.22M +$14.8K +1.2% 01 Oct 2020 31 Dec 2020 10-K 22 Mar 2022
Q3 2020 -$14M -$10.5M -$1.56M -17.4% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021
Q2 2020 -$12.4M -$982K +$396K +28.7% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q1 2020 -$12.8M -$1.23M +$96.4K +7.26% 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021
Q4 2019 -$12.9M -$1.23M +$405K +24.7% 01 Oct 2019 31 Dec 2019 10-K 16 Mar 2021
Q3 2019 -$13.3M -$8.95M -$7.13M -393% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020
Q2 2019 -$6.16M -$1.38M +$615K +30.9% 01 Apr 2019 30 Jun 2019 10-Q 12 Aug 2020
Q1 2019 -$6.78M -$1.33M +$501K +27.4% 01 Jan 2019 31 Mar 2019 10-Q 14 May 2020
Q4 2018 -$7.28M -$1.64M -$6.07M -137% 01 Oct 2018 31 Dec 2018 10-K 26 Mar 2020
Q3 2018 -$1.21M -$1.81M +$426K +19% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019
Q2 2018 -$1.63M -$1.99M +$910K +31.3% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019
Q1 2018 -$2.54M -$1.83M +$1.03M +36% 01 Jan 2018 31 Mar 2018 10-Q 13 May 2019
Q4 2017 -$3.57M $4.43M +$4.5M 01 Oct 2017 31 Dec 2017 10-K 29 Mar 2019
Q3 2017 -$8.06M -$2.24M +$11.1K +0.49% 01 Jul 2017 30 Sep 2017 10-Q 09 Nov 2018
Q2 2017 -$8.08M -$2.9M +$40.4M +93.3% 01 Apr 2017 30 Jun 2017 10-Q 10 Aug 2018
Q1 2017 -$48.4M -$2.86M -$1M -54.2% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018
Q4 2016 -$47.4M -$64.4K +$2.63M +97.6% 01 Oct 2016 31 Dec 2016 10-K 30 Mar 2018
Q3 2016 -$50.1M -$2.25M +$1.55M +40.8% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017
Q2 2016 -$51.6M -$43.3M -$41.9M -3083% 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017
Q1 2016 -$9.7M -$1.85M +$119K +6.02% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017
Q4 2015 -$9.82M -$2.69M +$1.53M +36.2% 01 Oct 2015 31 Dec 2015 10-K 31 Mar 2017
Q3 2015 -$11.3M -$3.8M -$692K -22.3% 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016
Q2 2015 -$10.7M -$1.36M +$1.28M +48.5% 01 Apr 2015 30 Jun 2015 10-Q 15 Aug 2016
Q1 2015 -$11.9M -$1.97M +$989K +33.4% 01 Jan 2015 31 Mar 2015 10-Q 16 May 2016
Q4 2014 -$12.9M -$4.22M -$4.14M -5394% 01 Oct 2014 31 Dec 2014 10-K 30 Mar 2016
Q3 2014 -$8.78M -$3.11M -$578K -22.9% 01 Jul 2014 30 Sep 2014 10-Q 16 Nov 2015
Q2 2014 -$8.21M -$2.64M -$1.61M -156% 01 Apr 2014 30 Jun 2014 10-Q 19 Aug 2015
Q1 2014 -$6.6M -$2.96M -$1.57M -113% 01 Jan 2014 31 Mar 2014 10-Q 20 May 2015
Q4 2013 -$5.03M -$76.8K -$65.5K -580% 01 Sep 2013 30 Nov 2013 10-Q 10 Jan 2014
Q3 2013 -$4.96M -$2.53M 01 Jul 2013 30 Sep 2013 10-Q 14 Nov 2014
Q2 2013 -$1.03M -$997K -2798% 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014
Q1 2013 -$1.39M -$1.36M -5218% 01 Jan 2013 31 Mar 2013 10-Q 20 May 2014
Q4 2012 -$11.3K +$3.54K +23.9% 01 Sep 2012 30 Nov 2012 10-Q 10 Jan 2014
Q2 2012 -$35.6K 01 Mar 2012 31 May 2012 10-Q 17 Jul 2013
Q1 2012 -$26.1K 01 Dec 2011 29 Feb 2012 10-Q 22 Apr 2013
Q4 2011 -$14.8K 01 Sep 2011 30 Nov 2011 10-Q 22 Jan 2013

Xenetic Biosciences, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$4.2M +$311K +6.89% 01 Jan 2024 31 Dec 2024 10-K 18 Mar 2025
2023 -$4.52M +$2.2M +32.8% 01 Jan 2023 31 Dec 2023 10-K 18 Mar 2025
2022 -$6.72M -$971K -16.9% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024
2021 -$5.75M +$8.19M +58.8% 01 Jan 2021 31 Dec 2021 10-K 22 Mar 2023
2020 -$13.9M -$1.05M -8.15% 01 Jan 2020 31 Dec 2020 10-K 22 Mar 2022
2019 -$12.9M -$5.61M -77.1% 01 Jan 2019 31 Dec 2019 10-K 16 Mar 2021
2018 -$7.28M -$3.71M -104% 01 Jan 2018 31 Dec 2018 10-K 26 Mar 2020
2017 -$3.57M +$43.9M +92.5% 01 Jan 2017 31 Dec 2017 10-K 29 Mar 2019
2016 -$47.4M -$37.6M -383% 01 Jan 2016 31 Dec 2016 10-K 30 Mar 2018
2015 -$9.82M +$3.1M +24% 01 Jan 2015 31 Dec 2015 10-K 31 Mar 2017
2014 -$12.9M -$4.31M -50.1% 01 Jan 2014 31 Dec 2014 10-K 30 Mar 2016
2013 -$8.61M -$2.27M -35.8% 01 Jan 2013 31 Dec 2013 10-K 20 Jul 2015
2012 -$6.34M 01 Jan 2012 31 Dec 2012 10-K 20 Jul 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.